Clinical Trials List
2017-06-30 - 2027-09-30
Phase III
Terminated4
ICD-10C34
Malignant neoplasm of bronchus and lung
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 陳焜結 Division of Thoracic Medicine
- TSUNG -YING YANG Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yung-Hung Luo Division of Thoracic Medicine
- 黃建勝 Division of Thoracic Medicine
- 蕭慈慧 Division of Thoracic Medicine
- Yi-Chen Yeh Division of Thoracic Medicine
- Hsu-ching Huang Division of Hematology & Oncology
- Chi-Lu Chiang Division of Thoracic Medicine
- 周德盈 Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Chao-Hua Chiu Division of Thoracic Medicine
- Yu-Chung Wu Division of Thoracic Medicine
- Heng-Sheng Chao 未分科
The Actual Total Number of Participants Enrolled
2 Terminated
Audit
None
Co-Principal Investigator
- Huey-En Tzeng Division of Hematology & Oncology
- CHIA-CHUN KUO Division of Hematology & Oncology
- Kai-Ling Lee Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
- Hsin-Lun Lee Division of Hematology & Oncology
- 禚靖 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
2 Terminated
Audit
None
Co-Principal Investigator
- Ching-Shan Luo Division of Hematology & Oncology
- Tzu-Tao Chen Division of Hematology & Oncology
- Po-Hao Feng Division of Hematology & Oncology
- Kuang-Tai Kuo Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
1 Terminated
Audit
CRO
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
326 participants
